Endotoxin induces differentiated contractile responses in porcine pulmonary arteries and veins

Journal of Vascular Research

Volumn 48, Issue 3, 2011, Pages 206-218

  Persson, Björn P ^a,d   Boels, Piet J M ^c   Lövdahl, Cecilia ^b   Rossi, Patrik ^a   Arner, Anders ^b   Oldner, Anders ^a  

^a Sections of A Anaesthesiology and Intensive Care Medicine   (Sweden)

^b Department of Physiology and Pharmacology   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute lung injury; Constriction; Endothelin 1; Immunohistochemistry; Pulmonary circulation; Relaxation; Western blot

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ENDOTOXIN; SARAFOTOXIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LUNG EDEMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; PULMONARY VEIN; SEPSIS; SWINE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MYOGRAPHY; ORGAN CULTURE TECHNIQUES; PULMONARY ARTERY; PULMONARY VEINS; RECEPTORS, ENDOTHELIN; SUS SCROFA; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 78449247885     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319796     Document Type: Article

References (51)

1. Baumgarten G, Knuefermann P, Wrigge H, Putensen C, Stapel H, Fink K, Meyer R, Hoef t A, Grohe C: Role of Toll-like receptor 4 for the pathogenesis of acute lung injury in Gram-negative sepsis. Eur J Anaesthesiol 2006; 23: 1041-104 8 . (Pubitemid 44622933)
2. Wang HM, Bodenstein M, Markstaller K: Overview of the pathology of three widely used animal models of acute lung injury. Eur Surg Res 2008; 40:305-316. (Pubitemid 351704903)
3. Rossi P, Wanecek M, Konrad D, Oldner A: Tezosentan counteracts endotoxin-induced pulmonary edema and improves gas exchange. Shock 2004; 21: 543-548.
4. Kabir K, Gelinas JP, Chen M, Chen D, Zhang D, Luo X, Yang JH, Carter D, Rabinovici R: Characterization of a murine model of endo-toxin-induced acute lung injury. Shock 2002; 17: 300-303.
5. Matsuda N, Hattori Y: Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 2007; 43:117-137.
6. Rossi P, Persson B, Boels PJ, Arner A, Weitz-berg E, Oldner A: Endotoxemic pulmonary hy per tension is largely me d iated by endot he-lin-induced venous constriction. Intensive Care Med 2008; 34: 873-880. (Pubitemid 351571188)
7. Battistini B, Dussault P: Biosynthesis, distribution and metabolism of endothelins in the pulmonary system. Pulm Pharmacol Ther 1998; 11 : 79-88. (Pubitemid 29041566)
8. Weitzberg E, Lundberg JM, Rudehill A: Elevated plasma levels of endothelin in patients with sepsis syndrome. Circ Shock 1991; 33: 222-227.
9. Mitaka C, Hirata Y, Nagura T, Tsunoda Y, Amaha K: Circulating endothelin-1 concentrations in acute respiratory failure. Chest 1993; 104:476-480. (Pubitemid 23229519)
10. Langleben D, DeMarchie M, Laporta D, Spa-nier AH, Schlesinger RD, Stewart DJ: Endo-thelin-1 in acute lung injury and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148: 1646-1650.
11. Druml W, Steltzer H, Waldhausl W, Lenz K, Hammerle A, Vierhapper H, Gasic S, Wagner OF: Endothelin-1 in adult respiratory distress syndrome. Am Rev Respir Dis 1993; 148 : 1169-1173 .
12. Persson BP, Rossi P, Weitzberg E, Oldner A: Inhaled tezosentan reduces pulmonary hypertension in endotoxin-induced lung injury. Shock 2009; 32:427-434.
13. Kuklin VN, Kirov MY, Evgenov OV, Sover-shaev MA, Sjoberg J, Kirova SS, Bjertnaes LJ: Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep. Crit Care Med 2004; 32:766-773. (Pubitemid 38340075)
14. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA 1988; 85: 9797-9800. (Pubitemid 19027212)
15. O'Brien AJ, Wilson AJ, Sibbald R, Singer M, Clapp LH: Temporal variation in endotoxin-induced vascular hyporeactivity in a rat mesenteric artery organ culture model. Br J Pharmacol 2001; 133: 351-360. (Pubitemid 33027771)
16. Foudi N, Kotelevets L, Louedec L, Leseche G, Henin D, Chastre E, Norel X: Vasorelaxation induced by prostaglandin e2 in human pulmonary vein: Role of the ep4 receptor subtype. Br J Pharmacol 2008; 154:1631-1639.
17. Fernandes D, da Silva-Santos JE, Duma D, Villela CG, Barja-Fidalgo C, Assreuy J: Nitric oxide-dependent reduction in soluble gua-nylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity. Mol Pharmacol 2006; 69: 983-990. (Pubitemid 43363873)
18. Parker JL, Adams HR: Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ Res 1993; 72:539-551. (Pubitemid 23052152)
19. Piepot HA, Groeneveld AB, van Lambalgen AA, Sipkema P: Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. J Surg Res 2003; 110:413-418. (Pubitemid 36683040)
20. Boels PJ, Deutsch J, Gao B, Haworth SG: Maturation of the response to bradykinin in resistance and conduit pulmonary arteries. Cardiovasc Res 1999; 44: 416-428. (Pubitemid 29474103)
21. Boels PJ, Deutsch J, Gao B, Haworth SG: Perinatal development influences mechanisms of bradykinin-induced relaxations in pulmonary resistance and conduit arteries differently. Cardiovasc Res 2001; 51: 140-150. (Pubitemid 32523063)
22. Bäck M, Walch L, Norel X, Gascard JP, Mazmanian G, Brink C: Modulation of vascular tone and reactivity by nitric oxide in porcine pulmonary arteries and veins. Acta Physiol Scand 2002; 174: 9-15. (Pubitemid 34122096)
23. Joiner PD, Kadowitz PJ, Hughes JP, Hyman AL: Ne and ach responses of intrapulmonary vessels from dog, swine, sheep, and man. Am J Physiol 1975; 228:1821-1827.
24. Gornemann T, von Wenckstern H, Kleuser B, Villalon CM, Centurion D, Jahnichen S, Pertz HH: Characterization of the postjunctional a2c-adrenoceptor mediating vasoconstriction to uk14304 in porcine pulmonary veins. Br J Pharmacol 2007; 151: 186-194. (Pubitemid 46763045)
25. Shebuski RJ, Ohlstein EH, Smith JM Jr, Ruf-folo RR Jr: Enhanced pulmonary ot-2 adrenoceptor responsiveness under conditions of elevated pulmonary vascular tone. J Pharmacol Exp Ther 1987; 242: 158-165. (Pubitemid 17112274)
26. Hyman AL, Kadowitz PJ: Evidence for existence of postjunctional c1-and (2-adrenoceptors in cat pulmonary vascular bed. Am J Physiol 1985; 249:H891-H898. (Pubitemid 16207235)
27. But AK, Ozgul U, Erdil F, Gulhas N, Toprak HI, Durmus M, Ersoy MO: The effects of pre-operative dexmedetomidine infusion on hemodynamics in patients with pulmonary hypertension undergoing mitral valve replacement surgery. Acta Anaesthesiol Scand 2006; 50:1207-1212. (Pubitemid 44624299)
28. Gao Y, Raj JU: Role of veins in regulation of pulmonary circulation. Am J Physiol Lung Cell Mol Physiol 2005; 288:L213-L226. (Pubitemid 40105361)
29. Walch L, de Montpreville V, Brink C, Norel X: Prostanoid EP(1)-and TP-receptors involved in the contraction of human pulmonary veins. Br J Pharmacol 2001; 134: 1671-1678. (Pubitemid 34038100)
30. Kemp BK, Smolich JJ, Cocks TM: Evidence for specific regional patterns of responses to different vasoconstrictors and vasodilators in sheep isolated pulmonary arteries and veins. Br J Pharmacol 1997; 121:441-450. (Pubitemid 27226296)
31. Shibamoto T, Wang HG, Yamaguchi Y, Hayashi T, Saeki Y, Tanaka S, Koyama S: Effects of thromboxane a2 analogue on vascular resistance distribution and permeability in isolated blood-perfused dog lungs. Lung 1995; 173:209-221.
32. Basu S: Novel cyclooxygenase-catalyzed bio-active prostaglandin f2a from physiology to new principles in inflammation. Med Res Rev 2007; 27:435-468. (Pubitemid 46991953)
33. Brink C, Gillard V, Roubert P, Mencia-Huer-ta JM, Chabrier PE, Braquet P, Verley J: Effects and specific binding sites of endothelin in human lung preparations. Pulm Pharmacol 1991; 4:54-59.
34. Toga H, Ibe BO, Raj JU: In vitro responses of ovine intrapulmonary arteries and veins to endothelin-1. Am J Physiol 1992; 263:L15-L21.
35. Aharinejad S, Schraufnagel DE, Miksovsky A, Larson EK, Marks SC Jr: Endothelin-1 focally constricts pulmonary veins in rats. J Thorac Cardiovasc Surg 1995; 110:148-156.
36. Zellers TM, McCormick J, Wu Y: Interaction among ET-1, endothelium-derived nitric oxide, and prostacyclin in pulmonary arteries and veins. Am J Physiol 1994; 267:H139-H147.
37. Sudjarwo SA, Hori M, Takai M, Urade Y, Okada T, Karaki H: A novel subtype of endothelin B receptor mediating contraction in swine pulmonary vein. Life Sci 1993; 53: 431-437.
38. Perkins GD, McAuley DF, Thickett DR, Gao F: The fS-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006; 173:281-287. (Pubitemid 43209082)
39. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, Hutter D, Turini P, Hugli O, Cook S, Nicod P, Scherrer U: Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002; 346: 1631-163 6 . (Pubitemid 34755671)
40. Johnsson E, Maddahi A, Wackenfors A, Edvinsson L: Enhanced expression of contractile endothelin ET(B) receptors in rat coronary artery after organ culture. Eur J Pharmacol 2008; 582:94-101.
41. Adner M, Uddman E, Cardell LO, Edvinsson L: Regional variation in appearance of vascular contractile endothelin-B receptors following organ culture. Cardiovasc Res 1998; 37: 254-262. (Pubitemid 28122639)
42. Nilsson D, Wackenfors A, Gustafsson L, Ugander M, Paulsson P, Ingemansson R, Ed-vinsson L, Malmsjo M: Endothelin receptor-mediated vasodilatation: effects of organ culture. Eur J Pharmacol 2008; 579: 233-240.
43. Piepot HA, Groeneveld AB, van Lambalgen AA, Sipkema P: The role of inducible nitric oxide synthase in lipopolysaccharide-medi-ated hyporeactivity to vasoconstrictors differs among isolated rat arteries. Clin Sci (Lond) 2002; 102: 297-305. (Pubitemid 34214392)
44. Foudi N, Louedec L, Cachina T, Brink C, Norel X: Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inf lammation. Cardiovasc Res 2009; 81: 269-277.
45. Fernandes D, Assreuy J: Nitric oxide and vascular reactivity in sepsis. Shock 2008; 30(suppl 1):10-13.
46. Kwok ES, Howes D: Use of methylene blue in sepsis: A systematic review. J Intensive Care Med 2006; 21:359-363. (Pubitemid 44664170)
47. El-Awady MS, Smirnov SV, Watson ML: De-sensitization of the soluble guanylyl cyclase/ cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta. Br J Pharmacol 2008;155:1164-1173.
48. Carlsson M, Lipcsey M, Larsson A, Tano E, Rubertsson S, Eriksson M, Sjolin J: Inflammatory and circulatory effects of the reduction of endotoxin concentration in established porcine endotoxemic shock-a model of endotoxin elimination. Crit Care Med 2009; 37:e1031-e1034.
49. Danner RL, Elin RJ, Hosseini JM, Wesley RA, Reilly JM, Parillo JE: Endotoxemia in human septic shock. Chest 1991; 99: 169-175 .
50. Guidet B, Barakett V, Vassal T, Petit JC, Of-fenstadt G: Endotoxemia and bacteremia in patients with sepsis syndrome in the intensive care unit. Chest 1994; 106:1194-1201. (Pubitemid 24309562)
51. Venet C, Zeni F, Viallon A, Ross A, Pain P, Gery P, Page D, Vermesch R, Bertrand M, R a ncon F, Bert rand JC: Endotoxaemia in patients with severe sepsis or septic shock. Intensive Care Med 2000; 26: 538-544. (Pubitemid 30325869)